CYTK — CYTOKINETICS INC

Ownership history in STEMPOINT CAPITAL LP  ·  5 quarters on record

This page tracks every 13F SEC filing in which STEMPOINT CAPITAL LP reported a position in CYTOKINETICS INC (CYTK). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
1.92% (2025 Q1)
Avg. % of fund
1.05%
First filed
2023 Q4
Last filed
2025 Q4
Quarters held
5
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 146,978 -2,670 -1.8% 1.60% $9.3M $63.54
2025 Q1 ADDED 149,648 +66,072 +79.1% 1.92% $6.0M $40.19
2024 Q4 ADDED 83,576 +69,112 +477.8% 0.98% $3.9M $47.04
2024 Q3 REDUCED 14,464 -9,647 -40.0% 0.23% $764K $52.80
2023 Q4 INITIATED 24,111 — — 0.54% $2.0M —
% of Fund (quarterly)    CYTK price (monthly, adj. close)

Other funds also holding CYTK

As of 2025 Q4 — sorted by position size

Foresite Capital Management IV, LLC 3Y 7Y 12.68% Sarissa Capital Management LP 3Y 7Y 11.3% DAFNA Capital Management LLC 3Y 7Y 5.48% Integral Health Asset Management, LLC 3Y 4.42% Rosalind Advisors, Inc. 4.36% Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. 4.22% Melqart Asset Management (UK) Ltd 3Y 7Y 3.9% Exome Asset Management LLC 3.79% Deep Track Capital, LP 3Y 3.78% Checkpoint Capital L.P. 3.31%
← Back to STEMPOINT CAPITAL LP Holdings